Glen E. Palmer

4.0k total citations
50 papers, 1.5k citations indexed

About

Glen E. Palmer is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Glen E. Palmer has authored 50 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Infectious Diseases, 28 papers in Epidemiology and 12 papers in Molecular Biology. Recurrent topics in Glen E. Palmer's work include Antifungal resistance and susceptibility (41 papers), Fungal Infections and Studies (22 papers) and Pneumocystis jirovecii pneumonia detection and treatment (7 papers). Glen E. Palmer is often cited by papers focused on Antifungal resistance and susceptibility (41 papers), Fungal Infections and Studies (22 papers) and Pneumocystis jirovecii pneumonia detection and treatment (7 papers). Glen E. Palmer collaborates with scholars based in United States, United Kingdom and Germany. Glen E. Palmer's co-authors include Brian M. Peters, Katherine S. Barker, P. David Rogers, Paul L. Fidel, Jeffrey M. Rybak, Joy Sturtevant, Mairi C. Noverr, Karen Eberle, Hubertine M. E. Willems and Andrew T. Nishimoto and has published in prestigious journals such as Nature Communications, PLoS ONE and Biological Psychiatry.

In The Last Decade

Glen E. Palmer

48 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Glen E. Palmer United States 21 1.1k 776 380 264 136 50 1.5k
Betty Wächtler Germany 8 977 0.9× 633 0.8× 272 0.7× 158 0.6× 70 0.5× 8 1.2k
Anna L. Lazzell United States 19 1.5k 1.3× 1.1k 1.4× 652 1.7× 215 0.8× 100 0.7× 26 1.9k
Marc Swidergall United States 21 902 0.8× 578 0.7× 334 0.9× 184 0.7× 224 1.6× 31 1.3k
Gloria Molero Spain 21 777 0.7× 518 0.7× 625 1.6× 95 0.4× 148 1.1× 42 1.4k
Carter L. Myers United States 8 928 0.8× 669 0.9× 311 0.8× 110 0.4× 87 0.6× 8 1.1k
Elisabetta Spreghini Italy 20 802 0.7× 621 0.8× 241 0.6× 127 0.5× 88 0.6× 36 1.1k
Fabien Cottier Singapore 21 626 0.6× 379 0.5× 563 1.5× 81 0.3× 114 0.8× 21 1.1k
Ashutosh Singh India 24 544 0.5× 397 0.5× 554 1.5× 108 0.4× 82 0.6× 49 1.2k
Matthew B. Lohse United States 18 1.0k 0.9× 603 0.8× 742 2.0× 121 0.5× 49 0.4× 30 1.6k
Megha Gulati United States 15 896 0.8× 458 0.6× 571 1.5× 202 0.8× 33 0.2× 20 1.5k

Countries citing papers authored by Glen E. Palmer

Since Specialization
Citations

This map shows the geographic impact of Glen E. Palmer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Glen E. Palmer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Glen E. Palmer more than expected).

Fields of papers citing papers by Glen E. Palmer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Glen E. Palmer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Glen E. Palmer. The network helps show where Glen E. Palmer may publish in the future.

Co-authorship network of co-authors of Glen E. Palmer

This figure shows the co-authorship network connecting the top 25 collaborators of Glen E. Palmer. A scholar is included among the top collaborators of Glen E. Palmer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Glen E. Palmer. Glen E. Palmer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ge, Wenbo, Tracy L. Peters, Bernd Meibohm, et al.. (2025). Pantothenate kinase is an effective target for antifungal therapy. Cell chemical biology. 32(5). 710–721.e6.
2.
Palmer, Glen E., et al.. (2024). Biophysical library screening using a Thermo-FMN assay to identify and characterize Clostridioides difficile FabK inhibitors. Biochemical and Biophysical Research Communications. 705. 149740–149740. 2 indexed citations
3.
Palmer, Glen E., et al.. (2022). Identifying Specific Small Molecule–Protein Interactions Using Target Abundance-Based Fitness Screening (TAFiS). Methods in molecular biology. 2542. 115–126. 1 indexed citations
4.
Liu, Junyan, Hubertine M. E. Willems, Stefanie Allert, et al.. (2021). A variant ECE1 allele contributes to reduced pathogenicity of Candida albicans during vulvovaginal candidiasis. PLoS Pathogens. 17(9). e1009884–e1009884. 48 indexed citations
5.
Rybak, Jeffrey M., José F. Muñoz, Katherine S. Barker, et al.. (2020). Mutations in TAC1B : a Novel Genetic Determinant of Clinical Fluconazole Resistance in Candida auris. mBio. 11(3). 135 indexed citations
6.
Roy, Bidisha, Jungsoo Han, Kevin A. Hope, et al.. (2020). An Unbiased Drug Screen for Seizure Suppressors in Duplication 15q Syndrome Reveals 5-HT1A and Dopamine Pathway Activation as Potential Therapies. Biological Psychiatry. 88(9). 698–709. 9 indexed citations
7.
Tournu, Hélène, Arielle Butts, & Glen E. Palmer. (2019). Titrating Gene Function in the Human Fungal Pathogen Candida albicans through Poly-Adenosine Tract Insertion. mSphere. 4(3). 5 indexed citations
8.
Souza, Ana Camila Oliveira, Qusai Al Abdallah, Adela Martín‐Vicente, et al.. (2019). Differential requirements of protein geranylgeranylation for the virulence of human pathogenic fungi. Virulence. 10(1). 511–526. 6 indexed citations
9.
Willems, Hubertine M. E., Josie E. Parker, Hélène Tournu, et al.. (2018). Loss of Upc2p-Inducible ERG3 Transcription Is Sufficient To Confer Niche-Specific Azole Resistance without Compromising Candida albicans Pathogenicity. mBio. 9(3). 20 indexed citations
10.
Butts, Arielle, Tracy L. Peters, Josie E. Parker, et al.. (2017). Target Abundance-Based Fitness Screening (TAFiS) Facilitates Rapid Identification of Target-Specific and Physiologically Active Chemical Probes. mSphere. 2(5). 11 indexed citations
11.
Richardson, Jonathan P., Hubertine M. E. Willems, David L. Moyes, et al.. (2017). Candidalysin Drives Epithelial Signaling, Neutrophil Recruitment, and Immunopathology at the Vaginal Mucosa. Infection and Immunity. 86(2). 137 indexed citations
12.
Tournu, Hélène, Jennifer L. Carroll, Brian Latimer, et al.. (2017). Identification of small molecules that disrupt vacuolar function in the pathogen Candida albicans. PLoS ONE. 12(2). e0171145–e0171145. 11 indexed citations
13.
Peters, Brian M., Karen Eberle, Timothy P. Foster, et al.. (2015). ERG2 and ERG24 Are Required for Normal Vacuolar Physiology as Well as Candida albicans Pathogenicity in a Murine Model of Disseminated but Not Vaginal Candidiasis. Eukaryotic Cell. 14(10). 1006–1016. 28 indexed citations
14.
Neumann, Donna M., et al.. (2013). Synthesis and antifungal activity of substituted 2,4,6-pyrimidinetrione carbaldehyde hydrazones. Bioorganic & Medicinal Chemistry. 22(2). 813–826. 60 indexed citations
15.
Zelante, Teresa, Rossana G. Iannitti, Antonella De Luca, et al.. (2012). Sensing of mammalian IL-17A regulates fungal adaptation and virulence. Nature Communications. 3(1). 683–683. 82 indexed citations
16.
Palmer, Glen E.. (2011). Vacuolar trafficking andCandida albicanspathogenesis. Communicative & Integrative Biology. 4(2). 240–242. 21 indexed citations
17.
Kelly, Michelle N., et al.. (2009). Bmh1p (14-3-3) mediates pathways associated with virulence in Candida albicans. Microbiology. 155(5). 1536–1546. 12 indexed citations
18.
Palmer, Glen E.. (2008). Chapter Twenty‐One Autophagy in Candida albicans. Methods in enzymology on CD-ROM/Methods in enzymology. 451. 311–322. 9 indexed citations
19.
Wozniak, Karen L., Glen E. Palmer, Robert Kutner, & Paul L. Fidel. (2005). Immunotherapeutic approaches to enhance protective immunity againstCandidavaginitis. Medical Mycology. 43(7). 589–601. 16 indexed citations
20.
Palmer, Glen E. & Joy Sturtevant. (2004). Random mutagenesis of an essential Candida albicans gene. Current Genetics. 46(6). 343–356. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Betty Wächtler Breakdown of academic impact, for papers by Anna L. Lazzell Breakdown of academic impact, for papers by Marc Swidergall Breakdown of academic impact, for papers by Gloria Molero Breakdown of academic impact, for papers by Carter L. Myers Breakdown of academic impact, for papers by Elisabetta Spreghini Breakdown of academic impact, for papers by Fabien Cottier Breakdown of academic impact, for papers by Ashutosh Singh Breakdown of academic impact, for papers by Matthew B. Lohse Breakdown of academic impact, for papers by Megha Gulati
Rankless by CCL
2026